Kumar Ranjit, Maynard Craig L, Eipers Peter, Goldsmith Kelly T, Ptacek Travis, Grubbs J Aaron, Dixon Paula, Howard Donna, Crossman David K, Crowley Michael R, Benjamin William H, Lefkowitz Elliot J, Weaver Casey T, Rodriguez J Martin, Morrow Casey D
Center for Clinical and Translational Sciences, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
BMC Microbiol. 2016 Jan 13;16:5. doi: 10.1186/s12866-015-0622-2.
Fecal microbiota transplants (FMT) are an effective treatment for patients with gut microbe dysbiosis suffering from recurrent C. difficile infections. To further understand how FMT reconstitutes the patient's gut commensal microbiota, we have analyzed the colonization potential of the donor, recipient and recipient post transplant fecal samples using transplantation in gnotobiotic mice.
A total of nine samples from three human donors, recipient's pre and post FMT were transplanted into gnotobiotic mice. Microbiome analysis of three donor fecal samples revealed the presence of a high relative abundance of commensal microbes from the family Bacteriodaceae and Lachnospiraceae that were almost absent in the three recipient pre FMT fecal samples (<0.01%). The microbe composition in gnotobiotic mice transplanted with the donor fecal samples was similar to the human samples. The recipient samples contained Enterobacteriaceae, Lactobacillaceae, Enterococcaceae in relative abundance of 43, 11, 8%, respectively. However, gnotobiotic mice transplanted with the recipient fecal samples had an average relative abundance of unclassified Clostridiales of 55%, approximately 7000 times the abundance in the recipient fecal samples prior to transplant. Microbiome analysis of fecal samples from the three patients early (2-4 weeks) after FMT revealed a microbe composition with the relative abundance of both Bacteriodaceae and Lachnospiraceae that was approximately 7% of that of the donor. In contrast, gnotobioitc mice transplanted with the fecal samples obtained from the three at early times post FMT revealed increases in the relative abundance of Bacteriodaceae and Lachnospiraceae microbe compositions to levels similar to the donor fecal samples. Furthermore, the unclassified Clostridiales in the recipient samples post FMT was reduced to an average of 10%.
We have used transplantation into gnotobiotic mice to evaluate the colonization potential of microbiota in FMT patients early after transplant. The commensal microbes present at early times post FMT out competed non-commensal microbes (e.g. such as unclassified Clostridiales) for niche space. The selective advantage of these commensal microbes to occupy niches in the gastrointestinal tract helps to explain the success of FMT to reconstitute the gut microbe community of patients with recurrent C. difficile infections.
粪便微生物群移植(FMT)是治疗肠道微生物群失调且患有复发性艰难梭菌感染患者的一种有效疗法。为了进一步了解FMT如何重建患者的肠道共生微生物群,我们通过在无菌小鼠中进行移植,分析了供体、受体以及受体移植后粪便样本的定殖潜力。
来自三名人类供体、受体FMT前后的总共九个样本被移植到无菌小鼠体内。对三个供体粪便样本的微生物组分析显示,拟杆菌科和毛螺菌科共生微生物的相对丰度很高,而在三个受体FMT前的粪便样本中几乎不存在(<0.01%)。移植了供体粪便样本的无菌小鼠中的微生物组成与人类样本相似。受体样本中肠杆菌科、乳杆菌科、肠球菌科的相对丰度分别为43%、11%、8%。然而,移植了受体粪便样本的无菌小鼠中未分类梭菌目的平均相对丰度为55%,约为移植前受体粪便样本中丰度的7000倍。对三名患者FMT后早期(2 - 4周)粪便样本的微生物组分析显示,拟杆菌科和毛螺菌科的微生物组成相对丰度约为供体的7%。相比之下,移植了FMT后早期从这三名患者获得的粪便样本的无菌小鼠显示,拟杆菌科和毛螺菌科微生物组成的相对丰度增加到与供体粪便样本相似的水平。此外,FMT后受体样本中未分类梭菌目平均减少到10%。
我们通过移植到无菌小鼠中,评估了FMT患者移植后早期微生物群的定殖潜力。FMT后早期存在的共生微生物在生态位空间上胜过非共生微生物(如未分类梭菌目)。这些共生微生物在胃肠道中占据生态位的选择性优势有助于解释FMT成功重建复发性艰难梭菌感染患者肠道微生物群落的原因。